Barely Significant
← all excerpts

A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies.

Cancer Res Commun · 2022 · PMC10010328 · PMID 36923283

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

did not reach statistical significanceP = 0.07so close (0.05 < p ≤ 0.1)
The effects were numerically more pronounced in the latter group, but this did not reach statistical significance (Mann—Whitney test, P = 0.07; Fig. 1A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.